Fatty liver disease — NAFLD explained

Non-alcohol related fatty liver disease (NAFLD) — now often termed MASLD (metabolic dysfunction-associated steatotic liver disease) in updated nomenclature — is excess fat in liver cells not primarily caused by alcohol.

It affects an estimated 20 to 30% of UK adults — parallel to obesity and type 2 diabetes epidemics. Most people never know they have it until blood tests or ultrasound for other reasons.

Spectrum of disease

StageNameRisk
Simple steatosisFat onlyLow — liver function often normal
NASHSteatohepatitis — inflammationModerate — can scar
FibrosisScarringProgressive
CirrhosisEnd-stage scarringLiver failure, cancer risk

Not everyone progresses — majority remain stable with simple fat.

Causes and risk factors

Alcohol: any intake adds injury — honest alcohol history essential — dual pathology common.

Symptoms

Early: asymptomatic

Later (cirrhosis):

  • fatigue
  • right upper abdominal discomfort
  • jaundice — yellow skin/eyes
  • itchy skin
  • ascites — fluid belly
  • leg swelling
  • easy bruising
  • confusion — encephalopathy

Diagnosis

GP pathway:

  1. Abnormal LFTs — raised ALT/AST (ALT often higher)
  2. Exclude other causes:
    • alcohol-related liver disease — AUDIT questionnaire
    • hepatitis B and C
    • autoimmune hepatitis
    • haemochromatosis — ferritin, transferrin saturation
    • coeliac disease — if indicated
  3. Ultrasound — bright liver, excludes focal lesions
  4. Fibrosis assessment — Fib-4 calculation, FibroScan in secondary care

Treatment — no magic pill (yet)

Weight loss — cornerstone

7 to 10% body weight loss:

Exercise

150 to 200 minutes weekly — improves enzymes independent of weight loss

Metabolic control

  • HbA1c targets in diabetes
  • statins — safe in NAFLD — reduce CV risk
  • blood pressure control

Medicines

  • vitamin E — selected non-diabetic NASH — specialist
  • pioglitazone — insulin sensitiser — specialist
  • GLP-1 agonists — emerging evidence for liver fat reduction in obesity/diabetes
  • no universal NHS pill for all NAFLD yet

Alcohol

** abstinence or minimal** — even moderate alcohol accelerates harm in fatty liver

Monitoring

Regular LFTs — track trend
Fibrosis reassessment if risk factors persist
Screen for cardiovascular disease — main cause of death in NAFLD patients

When to worry

Urgent referral:

  • jaundice
  • ascites
  • variceal bleed
  • platelets falling, albumin low — synthetic function failing

Fatty liver is reversible early — weight and metabolic health are treatment; ignoring abnormal LFTs risks preventable cirrhosis.

Common questions about fatty liver disease

What causes a fatty liver?
Excess calories stored as fat in liver cells — strongly linked to obesity, insulin resistance, type 2 diabetes, high cholesterol, and metabolic syndrome. Less commonly rapid weight loss, certain medicines, or genetic factors. Alcohol-related fatty liver is separate diagnosis — alcohol intake must be assessed honestly.
Can fatty liver be reversed?
Yes — weight loss of 5 to 10% body weight reduces liver fat and inflammation in most people. Exercise improves liver enzymes even without major weight loss. Controlling diabetes and cholesterol helps. Simple fatty liver often fully reverses; scarring (fibrosis) may be partially reversible early.
What are the symptoms of fatty liver disease?
Usually none — discovered on routine blood tests (raised ALT) or ultrasound. Advanced disease — tiredness, discomfort upper right abdomen, jaundice, itchy skin, swollen legs or abdomen — signs of cirrhosis. Most never reach this stage with lifestyle intervention.
Is fatty liver dangerous?
Simple steatosis is low short-term risk. NASH with inflammation and fibrosis can progress to cirrhosis, liver failure, and liver cancer over years — similar pathways to alcohol cirrhosis. Cardiovascular disease risk is also elevated — manage heart risk factors.
What should I eat for fatty liver?
Mediterranean-style diet — vegetables, whole grains, olive oil, fish; limit sugary drinks, refined carbs, and processed food. No specific miracle food — calorie deficit if overweight matters most. Coffee may have modest protective association in studies — not a treatment alone.
Do I need a liver biopsy?
Not routinely — non-invasive scores (Fib-4, ELF test, FibroScan) estimate fibrosis in many cases. Biopsy reserved for uncertain diagnosis or research — specialist decision.

Sources

How we reviewed this page

Medically reviewed by the HealthAnswers UK doctor review panel

First published
Medically reviewed
Next review due
or sooner if NHS or NICE guidance changes

Written by HealthAnswers editorial team. Published by HealthAnswers (Elite Digital AI Solutions Ltd). How we review content · Report a problem with this page